Candriam S.C.A. Grows Stake in Cardinal Health, Inc. $CAH

Candriam S.C.A. lifted its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 607.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 177,008 shares of the company’s stock after purchasing an additional 151,988 shares during the period. Candriam S.C.A. owned 0.07% of Cardinal Health worth $29,739,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the company. MassMutual Private Wealth & Trust FSB increased its position in Cardinal Health by 3.6% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock worth $297,000 after buying an additional 62 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its position in shares of Cardinal Health by 0.4% during the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock valued at $2,991,000 after buying an additional 69 shares during the last quarter. Perigon Wealth Management LLC grew its stake in shares of Cardinal Health by 3.2% during the 2nd quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock worth $389,000 after acquiring an additional 72 shares during the period. Community Bank & Trust Waco Texas increased its holdings in Cardinal Health by 1.3% in the 2nd quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company’s stock worth $940,000 after acquiring an additional 74 shares during the last quarter. Finally, Atlantic Edge Private Wealth Management LLC raised its stake in Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after acquiring an additional 75 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Insider Activity

In other news, insider Michelle D. Greene sold 13,500 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the transaction, the insider owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. The trade was a 47.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Stephen M. Mason sold 41,575 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the transaction, the chief executive officer owned 26,085 shares in the company, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 271,676 shares of company stock worth $40,489,525. Company insiders own 0.12% of the company’s stock.

Cardinal Health Price Performance

NYSE CAH opened at $205.94 on Friday. The company’s 50 day simple moving average is $164.46 and its two-hundred day simple moving average is $158.49. Cardinal Health, Inc. has a 1 year low of $114.60 and a 1 year high of $207.47. The stock has a market capitalization of $48.93 billion, a PE ratio of 31.93, a P/E/G ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm had revenue of $64.01 billion for the quarter, compared to analysts’ expectations of $59.41 billion. During the same quarter in the prior year, the firm posted $1.88 earnings per share. The business’s quarterly revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Argus raised their price objective on shares of Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a report on Tuesday, November 4th. Evercore ISI lifted their price objective on shares of Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research note on Friday, October 31st. TD Cowen increased their target price on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, November 3rd. Finally, Robert W. Baird set a $232.00 price target on Cardinal Health in a report on Friday, October 31st. Twelve equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $205.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.